Medulloblastoma is the most common malignant brain tumour of childhood. Although 70% of patients can be cured, the aggressive treatments leave many survivors with significant mental and physical disabilities. Professor Pilkington is developing a new approach to the treating of childhood medulloblastoma that could impact on both survival rates and quality of survival for young patients.
Medulloblastoma is the most common malignant brain tumour in children. We can now cure 70 per cent of children affected by it, but the necessarily aggressive treatments can leave them with significant disability. Dr Amin wants to develop a new way of delivering chemotherapy directly to the tumour. Success could ultimately result in the development of a much-needed, less damaging ...Read more